InMed Pharmaceuticals (INM) Change in Cash (2019 - 2026)
InMed Pharmaceuticals (INM) posted quarterly Change in Cash of -$1.5 million for Q1 2026, down 216.11% year-over-year from $1.3 million in Q1 2025, and up 38.41% quarter-over-quarter from -$2.4 million in Q4 2025.
InMed Pharmaceuticals (INM) Change in Cash (2019 - 2026) Analysis & Trends
InMed Pharmaceuticals' Change in Cash history runs 8 years deep, the most recent figure standing at -$1.5 million for Q1 2026.
- In Q1 2026, Change in Cash fell 216.11% year-over-year to -$1.5 million; the TTM figure through Mar 2026 stood at $811547.0 (up 127.79% YoY), while the FY2025 annual figure was $4.5 million, up 292.42% from the prior year.
- Change in Cash for Q1 2026 stood at -$1.5 million, up from -$2.4 million in the prior quarter.
- The five-year high for Change in Cash was $6.4 million in Q2 2025, with the low at -$5.4 million in Q1 2022.
- The 5-year median for Change in Cash is -$1.0 million (2024), against an average of -$340505.4.
- The sharpest annual moves came in 2022 and 2025: Change in Cash slumped 849.58% in 2022, then surged 721.59% in 2025.
- InMed Pharmaceuticals' Change in Cash stood at $2.1 million in 2022, then surged by 33.04% to $2.8 million in 2023, then slumped by 177.37% to -$2.2 million in 2024, then declined by 9.83% to -$2.4 million in 2025, then jumped by 38.41% to -$1.5 million in 2026.
- Business Quant data shows INM's Change in Cash at -$1.5 million in Q1 2026, -$2.4 million in Q4 2025, and -$1.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.96 Bn | 43.00 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.23 Bn | 39.58 Bn | 2.15 Bn | -86.00 Mn |
| 3 | Zoetis | 31.76 Bn | 30.08 Bn | 1.05 Bn | -465.00 Mn |
| 4 | Takeda Pharmaceutical | 28.68 Bn | 22.88 Bn | 5.10 Bn | -881.03 Mn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 523.50 Mn |
| 6 | Viatris | 18.69 Bn | 17.81 Bn | 1.46 Bn | -915.70 Mn |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | 64.40 Mn |
| 8 | Elanco Animal Health | 11.78 Bn | 11.25 Bn | 798.00 Mn | 102.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | InMed Pharmaceuticals | 6.48 Mn | 1.24 Mn | - | -1.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.46 Mn |
| Dec 31, 2025 | -2.38 Mn |
| Sep 30, 2025 | -1.74 Mn |
| Jun 30, 2025 | 6.40 Mn |
| Mar 31, 2025 | 1.26 Mn |
| Dec 31, 2024 | -2.16 Mn |
| Sep 30, 2024 | -988,571.00 |
| Jun 30, 2024 | -1.03 Mn |
| Mar 31, 2024 | -1.93 Mn |
| Dec 31, 2023 | 2.80 Mn |
| Sep 30, 2023 | -2.17 Mn |
| Jun 30, 2023 | -691,540.00 |
| Mar 31, 2023 | -1.85 Mn |
| Dec 31, 2022 | 2.10 Mn |
| Sep 30, 2022 | 3.17 Mn |
| Jun 30, 2022 | 278,553.00 |
| Mar 31, 2022 | -5.38 Mn |
| Dec 31, 2021 | -4.06 Mn |
| Sep 30, 2021 | 7.98 Mn |
| Jun 30, 2021 | -2.09 Mn |